Abstract
A lanthanide coordination polymer (Ln-CP), {Pr2(PBA)3(H2O)3]·DMF·3H2O}n (1), was synthesized using 5-(4-pyridin-3-yl-benzoylamino)-isophthalic acid (H2PBA), a tripodal carboxylic ligand. Moreover, the relative expression of miR-107 was evaluated through RT-PCR. miR-107 effect was then detected with the CCK-8 assay. ROS detection and ELISA were used to assess the inflammatory response in retinal vascular cells. miR-107 downstream regulation was also investigated. TargetScan was applied to predict the latent proteins that bind to miR-107 via the 3′-UTR, which was demonstrated in-depth through luciferase activity assay. All outcomes indicated that the miR-107 level was lower in retinal vascular cells in a diabetic retinopathy (DR) model. miR-107 expression could further regulate the proliferation of retinal vascular cells and inhibit inflammation, thereby playing a protective role in the function of retinal vascular cells. Thus, miR-107 may be an upstream regulatory factor of high-mobility group box 1, and let 7-5p may be a latent molecular target to treat DR.
Similar content being viewed by others
Data Availability
The data used to support the findings of this study are included within the article.
Change history
30 January 2024
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1007/s10876-024-02573-5
References
N. Cheung, P. Mitchell, and T. Y. Wong (2010). Lancet 376, 124–136.
L. Z. Heng, O. Comyn, T. Peto, C. Tadros, E. Ng, S. Sivaprasad, and P. G. Hykin (2013). Diabet. Med. 30, 640–650.
A. J. Duraisamy, R. Radhakrishnan, B. Seyoum, G. W. Abrams, and R. A. Kowluru (2019). Transl. Vis. Sci. Technol. 8, 43.
A. J. Jenkins, M. V. Joglekar, A. A. Hardikar, A. C. Keech, D. N. O’Neal, and A. S. Januszewski (2015). Rev. Diabet. Stud. 12, 159–195.
M. Zendjabil, S. Favard, C. Tse, O. Abbou, and B. Hainque (2017). C. R. Biol. 340, 114–131.
J. Cui, B. Zhou, S. A. Ross, and J. Zempleni (2017). Adv. Nutr. 8, 105–112.
S. R. Baier, C. Nguyen, F. Xie, J. R. Wood, and J. Zempleni (2014). J. Nutr. 144, 1495–1500.
P. Chen, X. Zhao, H. Wang, M. Zheng, Q. Wang, and W. Chang (2019). OncoTargets Ther. 12, 11017–11031.
R. Sen, A. Halder, and D. Ghoshal (2020). Polyhedron 183, 114534.
M. L. Hu, S. A. Razavi, M. Piroozzadeh, and A. Morsali (2020). Inorg. Chem. Front. 7, 1598–1632.
L. D. Ye, F. Rouhani, H. Kaviani, Q. Miao, X. Q. Cai, A. Morsali, and M. L. Hu (2021). J. Phys. Chem. C 125, 22951–22959.
R. F. Li, R. H. Li, X. F. Liu, X. H. Chang, and X. Feng (2020). RSC Adv. 10, 6192–6199.
R. F. Li, Y. W. Zhang, X. F. Liu, X. H. Chang, and X. Feng (2020). Inorg. Chim. Acta 502, 119370.
L. Fan, D. Zhao, B. Li, F. Wang, Y. Deng, Y. Peng, X. Wang, and X. Zhang (2022). Spectrochim. Acta A 264, 120232.
F. Wang, F. Tian, Y. Deng, L. Yang, H. Zhang, D. Zhao, B. Li, X. Zhang, and L. Fan (2021). Cryst. Growth Des. 21, 4242–4248.
C. Ma, H. Du, J. Liu, L. Kang, X. Du, X. Xi, and H. Ran (2021). Ceram. Int. 47, 25029–25036.
H. P. Ran, H. L. Du, C. Y. Ma, Y. Y. Zhao, D. N. Feng, and H. Xu (2021). Sci. Adv. Mater. 13, 741–747.
S. R. Banerjee, E. J. Ngen, M. W. Rotz, S. Kakkad, A. Lisok, R. Pracitto, M. Pullambhatla, Z. Chen, T. Shah, D. Artemov, T. J. Meade, Z. M. Bhujwalla, and M. G. Pomper (2015). Angew. Chem. Int. Ed. 54, 10778–10782.
Z. Abbas, S. Dasari, and A. K. Patra (2017). RSC Adv. 7, 44272–44281.
L. Sun, B. Devakumar, B. Li, J. Liang, H. Guo, and X. Huang (2018). RSC Adv. 8, 23284–23293.
K. Andiappan, A. Sanmugam, E. Deivanayagam, K. Karuppasamy, H. S. Kim, and D. Vikraman (2018). Sci. Rep. 8, 3054.
H. Zhu, J. Fu, S. Chen, X. Li, H. Liang, Y. Hou, and H. Dou (2019). Int. Immunopharmacol. 79, 106105.
W. He, L. Huang, M. Li, Y. Yang, Z. Chen, and X. Shen (2017). Cell Physiol. Biochem. 44, 792–803.
D. H. Zheng, X. Wang, L. N. Lu, D. L. Chen, J. M. Chen, F. M. Lin, and X. B. Xu (2018). Eur. Rev. Med. Pharmacol. Sci. 22, 7798–7806.
L. Dong, Y. Zhang, X. Wang, Y. X. Dong, L. Zheng, Y. J. Li, and J. M. Ni (2017). Chin. J. Integr. Med. 23, 528–534.
X. B. Zhou, L. F. Lai, G. B. Xie, C. Ding, X. Xu, and Y. Wang (2020). Neurol. Res. 42, 8–16.
X. Zhang, K. Jin, J. D. Luo, B. Liu, and L. P. Xie (2019). Neoplasma 66, 704–716.
Y. Fu, L. Lin, and L. Xia (2019). Cell Mol. Biol. Lett. 24, 31.
S. Ke, Z. Yang, F. Yang, X. Wang, J. Tan, and B. Liao (2019). Yonsei Med. J. 60, 640–650.
Y. Zhang, H. Zhang, Z. Zhang, S. Li, W. Jiang, X. Li, and J. Lv (2019). Mol. Immunol. 112, 22–29.
Acknowledgements
Not applicable.
Funding
The research was funded by Natural Science Foundation of Shandong Province (ZR2015HL112) and Science and Technology Development Plan of Tai’an City (2017NS0171).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The author(s) declare(s) that there is no conflict of interest regarding the publication of this paper.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1007/s10876-024-02573-5
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yu, FF., Du, YH. & Pang, GL. RETRACTED ARTICLE: Treatment Activity of a New Pr(III) Coordination Polymer on Diabetic Retinopathy by Regulating miR-107/HMGB1 in Retinal Vascular Cells. J Clust Sci 34, 1185–1194 (2023). https://doi.org/10.1007/s10876-021-02200-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10876-021-02200-7